(Q34529647)

2 August 2017

title

Vaccinia scars associated with better survival for adults. An observational study from Guinea-Bissau (English)

1 reference

2 August 2017

1 reference

Peter Aaby

1

0 references

Christine Stabell Benn

8

object named as

Christine Stabell Benn

1 reference

2 August 2017

6

Morten Sodemann

1 reference

2 August 2017

4

Amabelia Rodrigues

1 reference

2 August 2017

9

May-Lill Garly

1 reference

2 August 2017

Per Gustafson

2

1 reference

2 August 2017

Adam Roth

3

1 reference

2 August 2017

Manuel Fernandes

5

1 reference

2 August 2017

Birgitta Holmgren

7

1 reference

2 August 2017

Ida Maria Lisse

10

1 reference

2 August 2017

Henrik Jensen

11

1 reference

2 August 2017

language of work or name

English

0 references

publication date

6 May 2006

1 reference

2 August 2017

1 reference

2 August 2017

volume

24

1 reference

2 August 2017

issue

29-30

1 reference

2 August 2017

page(s)

5718-5725

1 reference

Non-specific beneficial effect of measles immunisation: analysis of mortality studies from developing countries

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.045

Routine vaccinations and child survival: follow up study in Guinea-Bissau, West Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.045

Childhood mortality among users and non-users of primary health care in a rural west African community

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.045

Divergent mortality for male and female recipients of low-titer and high-titer measles vaccines in rural Senegal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.045

Male biased mortality among 1-2 year old children in rural Malawi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.045

BCG scar and positive tuberculin reaction associated with reduced child mortality in West Africa. A non-specific beneficial effect of BCG?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.045

Child mortality following standard, medium or high titre measles immunization in West Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.045

Routine vaccinations and child survival in a war situation with high mortality: effect of gender

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.045

Differences in female-male mortality after high-titre measles vaccine and association with subsequent vaccination with diphtheria-tetanus-pertussis and inactivated poliovirus: reanalysis of West African studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.045

Primary induction of human CD8+ cytotoxic T lymphocytes and interferon-gamma-producing T cells after smallpox vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.045

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.045

Nutritional status and mortality of refugee and resident children in a non-camp setting during conflict: follow up study in Guinea-Bissau

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.045

Dual infections with HIV-1, HIV-2 and HTLV-I are more common in older women than in men in Guinea-Bissau.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.045

9-year HIV-2-associated mortality in an urban community in Bissau, west Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.045

Declining HIV-2 prevalence and incidence among men in a community study from Guinea-Bissau

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.045

The survival benefit of measles immunization may not be explained entirely by the prevention of measles disease: a community study from rural Bangladesh

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.045

Low mortality after mild measles infection compared to uninfected children in rural west Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.045

Childhood factors in ulcerative colitis and Crohn's disease. An international cooperative study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.045

Inverse association between melanoma and previous vaccinations against tuberculosis and smallpox: results of the FEBIM study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.045

Prior immunisation of patients with malignant melanoma with vaccinia or BCG is associated with better survival. An European Organization for Research and Treatment of Cancer cohort study on 542 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.045

Smallpox vaccination and risk of allergy and asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.045

The Swedish childhood diabetes study. Vaccinations and infections as risk determinants for diabetes in childhood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.045

Immunization in the first month of life may explain decline in incidence of IDDM in The Netherlands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.045

Measles vaccination and reduction in child mortality: a community study from Guinea-Bissau

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.045

No persistent T lymphocyte immunosuppression or increased mortality after measles infection: a community study from Guinea-Bissau.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.045

No Long-term Excess Mortality after Measles Infection: A Community Study from Senegal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.045

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.045

The new cell culture smallpox vaccine should be offered to the general population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.045

The new cell culture smallpox vaccine should not be offered to the general population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.045

10.1016/J.VACCINE.2006.04.045

7 January 2021

Identifiers

DOI

1 reference

2 August 2017

1 reference